| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.82▲ | 2.82▲ | 2.82▲ | 2.79▲ | 2.45▲ |
| MA10 | 2.81▲ | 2.82▲ | 2.78▲ | 2.82▲ | 2.18▲ |
| MA20 | 2.81▲ | 2.78▲ | 2.82▲ | 2.37▲ | 1.93▲ |
| MA50 | 2.82▲ | 2.81▲ | 2.83▲ | 2.07▲ | 1.97▲ |
| MA100 | 2.78▲ | 2.83▲ | 2.56▲ | 1.88▲ | 2.24▲ |
| MA200 | 2.81▲ | 2.50▲ | 2.23▲ | 1.92▲ | 2.98▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.007▲ | 0.005▲ | 0.029▲ | 0.123▲ |
| RSI | 59.693▲ | 54.350▲ | 52.675▲ | 63.670▲ | 67.317▲ |
| STOCH | 56.250 | 50.145 | 79.920 | 70.400 | 64.709 |
| WILL %R | -12.500▲ | -14.894▲ | -13.462▲ | -16.245▲ | -14.901▲ |
| CCI | 185.714▲ | 52.837 | 75.991 | 50.415 | 170.061▲ |
|
Thursday, November 20, 2025 04:14 AM
GT-02287 reduces mitochondrial stress and enhances neuronal survival in MPP+ treated rat dopaminergic neurons GT-02287 decreases staining for MIRO1, suggesting improved mitochondrial health in ...
|
|
Wednesday, November 12, 2025 04:08 AM
Presented initial data from Phase 1b study suggesting GT-02287 has a disease-slowing effect consistent with the preclinical models in vivo and ...
|
|
Thursday, October 30, 2025 12:00 AM
BETHESDA, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/11/25 | 2.76 | 2.87 | 2.76 | 2.835 | 621,677 |
| 21/11/25 | 2.83 | 2.87 | 2.60 | 2.66 | 971,257 |
| 20/11/25 | 2.75 | 3.05 | 2.74 | 2.85 | 1,522,817 |
| 19/11/25 | 2.83 | 2.90 | 2.67 | 2.75 | 539,755 |
| 18/11/25 | 2.79 | 2.86 | 2.66 | 2.85 | 1,020,596 |
| 17/11/25 | 2.87 | 3.04 | 2.78 | 2.82 | 469,634 |
| 14/11/25 | 2.92 | 3.06 | 2.78 | 2.83 | 1,192,168 |
| 13/11/25 | 2.93 | 2.99 | 2.53 | 2.99 | 1,997,301 |
| 12/11/25 | 2.96 | 3.03 | 2.65 | 2.95 | 3,642,191 |
| 11/11/25 | 2.50 | 2.68 | 2.35 | 2.68 | 1,406,276 |
|
|
||||
|
|
||||
|
|